56: Multiple RTK targeting as a therapeutic option in malignant pleural mesothelioma

Autor:	David J. Easty, Annette T. Byrne, Dean A. Fennell, Steven G. Gray, Chandra Goparju, Martin P. Barr, Daisuke Nonaka, Gareth Clarke, I. Schmitt-Opitz, Kieran Crosbie-Staunton, S.P. Finn, Yuri Volkov, Bryan Stanfill, A.M. Baird, Sinead Cuffe, Kenneth J. O'Byrne, Dearbhaile M. O'Donnell, Adriele Prina-Mello, Bruno Murer, L. Mcdonagh, S. Raeppel, Monika A. Jarzabek, Bashir M. Mohamed, Liam Shiels, Harvey I. Pass, Alex Soltermann, Luciano Mutti
Rok vydání:	2017
Předmět:	Pulmonary and Respiratory Medicine Oncology Cancer Research medicine.medical_specialty Pleural mesothelioma business.industry Cancer medicine.disease_cause medicine.disease Asbestos respiratory tract diseases Surgery Internal medicine medicine business Median survival
Zdroj:	Lung Cancer. 103:S26
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(17)30106-x
Popis:	Malignant pleural mesothelioma (MPM) is an aggressive inflammatory cancer associated with exposure to asbestos. Untreated, MPM has a median survival time of 6 months,and most patients die within two years of diagnosis. There is an urgent need to identify new therapies for treating MPM patients.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4e9ff3c0aa6beb8d4320e44d5c5b7cd0 https://doi.org/10.1016/s0169-5002(17)30106-x Zobrazit plný text záznamu Full Text from ScienceDirect